✦ LIBER ✦

Treating two concurrent B-cell and T-cell lymphoid neoplasms with alemtuzumab monotherapy

✍ Scribed by Niccolò Bolli; Mauro Di Ianni; Stefano Simonetti; Lorenzo Cerroni; Arcangelo Liso; Brunangelo Falini; Antonio Tabilio

Book ID: 117783084
Publisher: The Lancet
Year: 2004
Tongue: English
Weight: 524 KB
Volume: 5
Category: Article
ISSN: 1470-2045
DOI: 10.1016/s1470-2045(03)01327-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

COEXISTENT LYMPHOID OR PLASMA CELL NEOPL

COEXISTENT LYMPHOID OR PLASMA CELL NEOPLASMS

✍ A. N. Stark; C. S. Scott; T. J. Hamblin; J. A. Copplestone; G. J. Mufti; D. G. O 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB

The Outcome of HyperCVAD Combined with A

The Outcome of HyperCVAD Combined with Alemtuzumab for the Treatment of Aggressive T-Cell and NK-Cell Neoplasms

✍ Jew Win Kuan; Kian Meng Chang; Ngee Siang Lau; Purushothaman Visalachy; Sen Mui 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 251 KB

The effect of cell synchronization upon

The effect of cell synchronization upon the detection of T and B lymphoid cell receptors on two continuous lymphoid cell lines

✍ Steven Krakowka; Richard Olsen; Gary Cockerell 📂 Article 📅 1977 🏛 Society for In Vitro Biology 🌐 English ⚖ 437 KB

Modulation of B and T cell subsets in mi

Modulation of B and T cell subsets in mice treated with fractionated total lymphoid irradiation. I. Blockage of differentiating B cell pathways

✍ Israel Zan-Bar 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 674 KB

Modulation of B and T cell subsets in mi

Modulation of B and T cell subsets in mice treated with fractionated total lymphoid irradiation. II. Tolerance susceptibility of B cell subsets

✍ Israel Zan-Bar 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 519 KB

Concurrent B-cell chronic lymphocytic le

Concurrent B-cell chronic lymphocytic leukemia and multiple myeloma treated successfully with lenalidomide

✍ Sridhar Srinivasan; Charles A. Schiffer 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 91 KB

The occurrence of multiple myeloma and chronic lymphocytic leukemia in the same patient is very uncommon. The immunomodulatory agent lenalidomide has been shown to have high response rates in multiple myeloma and appears to be quite active in advanced CLL. We report two patients with concurrent CLL